BioSpace News Archive

How to Become a Top Performer When You Didn’t Get Enough Training

If you aren’t properly trained it can be very difficult to achieve successful results. Here’s how to become a top performer, even when you didn’t get enough training.

February 26, 2019

·

3 min read

·

Porschia Parker-Griffin

Job Trends

Amicus Therapeutics to Hire 200 Researchers at New Gene Therapy Center in Philadelphia

Amicus Therapeutics, headquartered in Cranbury, New Jersey, announced it is launching a Global Research and Gene Therapy Center of Excellence in Philadelphia.

February 26, 2019

·

3 min read

·

Mark Terry

Pharm Country

Oyster Point Pharma Scores $93 Million Series B to Focus Its Gaze on Dry Eye Disease

The company’s two lead product candidates are OC-01 and OC-02, which are delivered by way of an ocular surface-sparing nasal spray that stimulates the trigeminal parasympathetic pathway to induce natural tear film production.

February 26, 2019

·

2 min read

·

Mark Terry

Courtesy of Roland Magnusson/Getty Images

Business

Lynparza Passes Phase III Pancreatic Cancer Trial With Flying Colors

The drug is being developed and commercialized jointly by AstraZeneca and Merck. It has already been approved for multiple indications in advanced ovarian cancer and metastatic breast cancer.

February 26, 2019

·

2 min read

·

Mark Terry

Business

Bacteriophages to the Rescue: A Possible Approach to Antibiotic Resistance

Ella Balasa, a 26-year-old from Richmond, Virginia, recently made the news when she was apparently successfully treated for a lung infection using a kind of virus called a bacteriophage.

February 26, 2019

·

3 min read

·

Mark Terry

Policy

Gang of 7 Pharma Execs Grilled by Congress

U.S. Senator Chuck Grassley (R-Iowa) set the tone early, mentioning his constituents rationing drugs because of high prices or “leaving their prescription on the pharmacy counter because it costs too much,” but acknowledging that innovations “take time and money.”

February 26, 2019

·

4 min read

·

Mark Terry

Business

Promore Pharma AB (publ) Year-end report 2018

The past year, 2018, was in many ways a decisive year for Promore Pharma

February 26, 2019

·

6 min read

Drug Development

Immunic Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of IMU-838, an Oral Therapy for Patients with Relapsing-Remitting Multiple Sclerosis

Immunic AG announced enrollment of the first patient in a phase 2 clinical study of IMU-838 for the treatment of patients with relapsing-remitting multiple sclerosis.

February 26, 2019

·

8 min read

FDA

Medtronic Resolute(TM) Drug-Eluting Stent (DES) Platform Receives Expanded Indication for Treatment of Chronic Total Occlusion (CTO)

FDA Approval Allows Interventional Cardiologists Access to Resolute DES Technology to Treat De Novo CTO

February 26, 2019

·

3 min read

Bio NC

IQVIA Report: Global Drug Spending to Hit $1.5 Trillion by 2023

The IQVIA Institute for Human Data Science published its Study on Global Medicine Spending. One of the findings is that total drug spending is expected to climb to more than $1.5 trillion by 2023. That’s a 50 percent increase from 2014.

February 26, 2019

·

2 min read

·

Mark Terry